RxSight (RXST) Q3 2026 Earnings Call Transcript
RxSight, Inc. Q3 2026 Earnings Call Summary
Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $8
Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $6
RxSight Inc (RXST) (Q3 2026) Earnings Call Highlights: Revenue Slides 19% as Sales Force ...
Needham Maintains Buy on RxSight, Lowers Price Target to $7
What RxSight (RXST) Said on Its Q3 Earnings Call
RxSight (NASDAQ:RXST) Q3 Revenue Miss and Margin Pressure Drive After-Market Selloff
RxSight, Inc. (RXST) Q3 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue Estimates
RxSight Q3 2026 Earnings Call Transcript
RxSight Q3 Adj. EPS $(0.21) Beats $(0.29) Estimate, Sales $24.586M Miss $27.137M Estimate
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says
B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $5.5
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?
RxSight (RXST) Q2 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.